{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:42:41Z","timestamp":1770471761844,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK124182"],"award-info":[{"award-number":["DK124182"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK084567"],"award-info":[{"award-number":["P30DK084567"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The underlying mechanisms contributing to cholestatic liver injury remain unclear. The pro-inflammatory leukocyte-restricted cytokine interleukin-17A (IL-17A) has been implicated in human cholestatic liver injury. However, mechanistic insights are lacking and require further exploration in preclinical models. Herein, we examined the effect of IL-17A genetic ablation in a mouse model of cholestatic liver injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Age and gender-matched littermate wild type (WT) and\n                      <jats:italic>Il-17a<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>-\/-<\/jats:italic>\n                      <\/jats:sup>\n                      C57BL\/6 mice were fed an intermittent 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet for 21 days to induce cholestatic liver injury or a control diet.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      As compared to WT littermates,\n                      <jats:italic>Il-17a<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>-\/-<\/jats:italic>\n                      <\/jats:sup>\n                      mice displayed more abundant desmin-positive myofibroblasts and increased fibrosis. NanoString analysis of intrahepatic leukocyte populations using a fibrosis-related gene panel identified upregulation of\n                      <jats:italic>Tnfsf14<\/jats:italic>\n                      (encoding the protein LIGHT) in the DDC-fed\n                      <jats:italic>Il-17a<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>-\/-<\/jats:italic>\n                      <\/jats:sup>\n                      mice. Although mass cytometry identified an increase in myeloid cells in both genotypes of the DDC-fed mice, we could not identify LIGHT expression in this cell lineage. Instead, the upregulation of LIGHT expression was largely restricted to a CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell population as assessed by flow cytometry. Enhanced LIGHT expression was observed in a Th1\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell population. LIGHT activated primary human hepatic stellate cells\n                      <jats:italic>in vitro,<\/jats:italic>\n                      suggesting that LIGHT stimulation of hepatic fibrogenesis may be direct.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Taken together, these data suggest that IL-17A restrains expression of the profibrogenic cytokine, LIGHT, by Th1-polarized CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, and implicate a role for LIGHT in cholestatic fibrogenesis in DDC-fed mice; a finding which requires validation in additional models.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0342251","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:44:53Z","timestamp":1770403493000},"page":"e0342251","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury"],"prefix":"10.1371","volume":"21","author":[{"given":"Takashi","family":"Kitagataya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsta E.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Baez-Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eugenia","family":"Guicciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-1315","authenticated-orcid":true,"given":"Kevin D.","family":"Pavelko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adiba I.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-009X","authenticated-orcid":true,"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"26","key":"pone.0342251.ref001","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis","volume":"373","author":"D Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0342251.ref002","doi-asserted-by":"crossref","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","article-title":"Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview","volume":"12","author":"C Schinocca","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0342251.ref003","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"RG Langley","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"pone.0342251.ref004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179773","article-title":"IL-17A in human liver: significant source of inflammation and trigger of liver fibrosis initiation","volume":"23","author":"D Kartasheva-Ebertz","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0342251.ref005","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"TH Karlsen","year":"2017","journal-title":"J Hepatol"},{"issue":"12","key":"pone.0342251.ref006","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"KN Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0342251.ref007","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"JE Eaton","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"pone.0342251.ref008","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2018.12.035","article-title":"Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis","volume":"70","author":"T Schmidt","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"pone.0342251.ref009","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced T-Helper 17 differentiation in patients with primary sclerosing cholangitis (PSC)","volume":"72","author":"LK Kunzmann","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"pone.0342251.ref010","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41591-023-02372-x","article-title":"Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis","volume":"29","author":"DG Shaw","year":"2023","journal-title":"Nat Med"},{"issue":"8","key":"pone.0342251.ref011","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"SL Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"pone.0342251.ref012","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"H Ishigame","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"pone.0342251.ref013","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"RM Onishi","year":"2010","journal-title":"Immunology"},{"issue":"5","key":"pone.0342251.ref014","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 Signaling: The Yin and the Yang","volume":"38","author":"N Amatya","year":"2017","journal-title":"Trends Immunol"},{"issue":"2","key":"pone.0342251.ref015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2009.03947.x","article-title":"Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis","volume":"157","author":"K Harada","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"pone.0342251.ref016","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"F Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"pone.0342251.ref017","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Z Tan","year":"2013","journal-title":"J Immunol"},{"issue":"11","key":"pone.0342251.ref018","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/ajg.2016.298","article-title":"A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn\u2019s disease","volume":"111","author":"SR Targan","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"pone.0342251.ref019","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"W Hueber","year":"2012","journal-title":"Gut"},{"issue":"4","key":"pone.0342251.ref020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-Independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"JS Lee","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"pone.0342251.ref021","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhep.2020.10.035","article-title":"IL-17A\/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression","volume":"74","author":"S Stein","year":"2021","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0342251.ref022","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ajpath.2020.02.013","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand receptor deficiency promotes the ductular reaction, macrophage accumulation, and hepatic fibrosis in the Abcb4-\/- mouse","volume":"190","author":"A Krishnan","year":"2020","journal-title":"Am J Pathol"},{"issue":"9","key":"pone.0342251.ref023","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3390\/cancers12092449","article-title":"Deciphering the immune microenvironment on a single archival formalin-fixed paraffin-embedded tissue section by an immediately implementable multiplex fluorescence immunostaining protocol","volume":"12","author":"A Guillot","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0342251.ref024","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.31067","article-title":"The spectrum of reactive cholangiocytes in primary sclerosing cholangitis","volume":"71","author":"ME Guicciardi","year":"2020","journal-title":"Hepatology"},{"issue":"7","key":"pone.0342251.ref025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"T Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"pone.0342251.ref026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"T Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"pone.0342251.ref027","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.4049\/jimmunol.168.10.4936","article-title":"Sustained NFAT signaling promotes a Th1-like pattern of gene expression in primary murine CD4+ T cells","volume":"168","author":"CM Porter","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"pone.0342251.ref028","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/j.gastro.2024.07.044","article-title":"Portal fibrosis and the ductular reaction: pathophysiological role in the progression of liver disease and translational opportunities","volume":"168","author":"V Gupta","year":"2025","journal-title":"Gastroenterology"},{"issue":"45","key":"pone.0342251.ref029","doi-asserted-by":"crossref","first-page":"42841","DOI":"10.1074\/jbc.M207689200","article-title":"Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control","volume":"277","author":"R Castellano","year":"2002","journal-title":"J Biol Chem"},{"key":"pone.0342251.ref030","doi-asserted-by":"crossref","first-page":"1219907","DOI":"10.3389\/fimmu.2023.1219907","article-title":"TNF superfamily control of tissue remodeling and fibrosis","volume":"14","author":"H Steele","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"pone.0342251.ref031","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlaf042","article-title":"LIGHT in combination with IL-13 or IL-17 drives inflammatory transcriptional signatures in human pulmonary fibroblasts relevant for human lung disease","volume":"9","author":"N Ghosh","year":"2025","journal-title":"Immunohorizons"},{"issue":"11","key":"pone.0342251.ref032","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00125-019-4962-6","article-title":"Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis","volume":"62","author":"A Herrero-Cervera","year":"2019","journal-title":"Diabetologia"},{"issue":"3","key":"pone.0342251.ref033","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s12276-021-00574-2","article-title":"Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK\/TGF-\u03b21 signaling pathway.","volume":"53","author":"QS Liang","year":"2021","journal-title":"Exp Mol Med"},{"issue":"1","key":"pone.0342251.ref034","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hep.22597","article-title":"Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury","volume":"49","author":"RG Ruddell","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"pone.0342251.ref035","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.11.018","article-title":"Nuclear translocation of RELB Is increased in diseased human liver and promotes ductular reaction and biliary fibrosis in mice","volume":"156","author":"C El\u00dfner","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"pone.0342251.ref036","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.dld.2023.08.057","article-title":"Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis","volume":"56","author":"S Kanai","year":"2024","journal-title":"Dig Liver Dis"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:45:01Z","timestamp":1770403501000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342251"}},"subtitle":[],"editor":[{"given":"Pavel","family":"Strnad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0342251","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}